ABECMA (idecabtagene vicleucel)
ABECMA is the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapies includ…
Thune Says Health Care Often ‘Comes With a Job.’ The Reality’s Not Simple or Straightforward.
“A lot of times, health care comes with a job.” Sen. John Thune (R-S.D.), in an interview with KOTA on May 30, 2025 Millions of…
Kennedy’s Vaccine Advisers Sow Doubts as Scientists Protest US Pivot on Shots
As fired and retired scientists rallied outside in the Atlanta heat, an advisory panel that Robert F. Kennedy Jr. handpicked to replace experts he’d fired…
Too Sick To Work, Some Americans Worry Trump’s Bill Will Strip Their Health Insurance
Stephanie Ivory counts on Medicaid to get treated for gastrointestinal conditions and a bulging disc that makes standing or sitting for long periods painful. Her…
California Immigrants Weigh Health Coverage Against Deportation Risk
For months, Maria, 55, a caregiver to older adults in Orange County, has been trying not to smile. If she opens her mouth too wide,…
FDA Eliminates Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies
The REMS for currently approved BCMA- and CD19-directed autologous chimeric antigen receptor (CAR) T cell immunotherapies have been eliminated because…
CARVYKTI
For the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including a proteasome inh…
Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions
This document provides FDA’s recommendations to industry regarding cybersecurity device design, labeling, and the documentation that FDA recommends …
KFF Health News’ ‘What the Health?’: Live From Aspen — Governors and an HHS Secretary Sound Off
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly…
NASA Mars Orbiter Learns New Moves After Nearly 20 Years in Space
After nearly 20 years of operations, NASA’s Mars Reconnaissance Orbiter (MRO) is on a roll, performing a new maneuver to squeeze even more science out…
